The Master in Drug Development and Clinical Application is aimed at creating specific managerial, regulatory and clinical skills in the field of drug development. The pharmaceutical companies in this sector are constantly looking for professionals who have specific knowledge of the development processes, from the lab bench to the patient's bed. Other employment targets for professionals coming out from this Master are health institutions involved in drug testing, or research organization companies (CROs), as well as scientific foundations and patient associations involved in the drug development process and application for drug approval.
Due to the Coronavirus emergency, the Master is suspended until a later date
The Master aims to train professionals able to know the details of the entire process of pharmaceutical development, including scientific research, industrial production, legislative aspects, as well as the organization and management of preclinical phases and clinical trials in humans. Physicians, biologists, biotechnologists, pharmacists, chemists, medical engineers are the ideal students for the courses provided during the Master.